2018
DOI: 10.4103/ajm.ajm_114_17
|View full text |Cite
|
Sign up to set email alerts
|

Type I Kounis syndrome variant: A case report and literature review

Abstract: Kounis syndrome defined as the occurrence of acute coronary syndrome in the setting of allergic reaction due to mast cells activation and inflammatory mediators release that induces coronary vasospasm, plaque erosion, or even stent thrombosis. A 25-year-old postpartum female with asthma and recurrent episodes of chest pain was admitted with ST-segment elevation myocardial infarction in the setting of coronary artery spasms. The patient was started on calcium channel blockers and nitrite-based medication with n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…Type 2 variant affects patients with pre-existing atheromatous disease in whom mediator-induced vasospasm is accompanied by plaque erosion or rupture that manifests as an acute myocardial infarction. Type 3 variant is seen in patients with coronary artery stent thrombosis secondary to eosinophils and mast cell activation [ 3 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Type 2 variant affects patients with pre-existing atheromatous disease in whom mediator-induced vasospasm is accompanied by plaque erosion or rupture that manifests as an acute myocardial infarction. Type 3 variant is seen in patients with coronary artery stent thrombosis secondary to eosinophils and mast cell activation [ 3 ].…”
Section: Discussionmentioning
confidence: 99%
“…Effective Kounis syndrome management entails treating anaphylaxis while maintaining adequate myocardial perfusion [ 3 , 5 ]. The initial goal of treatment should be to prevent life-threatening anaphylaxis while keeping in mind that some medications may affect coronary blood flow.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Type I variant is characterized by allergy-related coronary spasm without coronary lesions or risk factors. Patients with type I Kounis syndrome present electrocardiographic change with or without cardiac enzymes elevation due to the acute release of inflammatory mediators inducing coronary spasm [4]. The type II variant includes pre-existing atheromatous disease.…”
Section: Discussionmentioning
confidence: 99%
“…For the treatment of the allergic reaction, both H1 and H2 antihistamines, such as diphenhydramine (1 to 2 mg/kg) and ranitidine (1 mg/kg) can be used. The use of H1 receptor blockers has been suggested in Kounis syndrome but in a low flow rate because these drugs can precipitate hypotension and compromise coronary flow [11]. Corticoids are an important part of the treatment of anaphylaxis but they may impair wound healing causing myocardial wall thinning and cardiac aneurysms.…”
Section: Discussionmentioning
confidence: 99%